These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31945346)

  • 1. Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.
    van de Kerkhof PCM
    J Invest Dermatol; 2020 Mar; 140(3):524-526. PubMed ID: 31945346
    [No Abstract]   [Full Text] [Related]  

  • 2. ESDR 2010-2020: Journey toward Translational and Systems Dermatology.
    Schmuth M; Biedermann T; Picardo M; Florestan T; Barker J
    J Invest Dermatol; 2020 Sep; 140(9S):S167-S170. PubMed ID: 32800164
    [No Abstract]   [Full Text] [Related]  

  • 3. Principles and considerations for effective academia-industry collaboration in pharmacoepidemiology.
    Ephross SA; Mitchell AA; Sacks S; Straus W; Stürmer T
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1153-1156. PubMed ID: 30232825
    [No Abstract]   [Full Text] [Related]  

  • 4. Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care.
    Tan C; McGill JM; Mallbris L
    J Invest Dermatol; 2020 Mar; 140(3):527-530. PubMed ID: 31972248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of academic medicine for innovations in development of drugs and biomedicine technology].
    Manns MP
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1993-4. PubMed ID: 24065403
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
    Mavilio F
    Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of academic medical centers in advancing regulatory science.
    Meyer RJ
    Clin Pharmacol Ther; 2014 May; 95(5):471-3. PubMed ID: 24747233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Skin Science Foundation: Promoting Skin Health through Research.
    Gilliet M; Griffiths CEM
    J Invest Dermatol; 2020 Sep; 140(9S):S189-S190. PubMed ID: 32800173
    [No Abstract]   [Full Text] [Related]  

  • 9. EATRIS, a vision for translational research in Europe.
    Becker R; van Dongen GA
    J Cardiovasc Transl Res; 2011 Jun; 4(3):231-7. PubMed ID: 21544739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 13. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
    Bryans JS; Kettleborough CA; Solari R
    Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
    [No Abstract]   [Full Text] [Related]  

  • 14. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.
    Broes S; Saesen R; Lacombe D; Huys I
    Clin Transl Sci; 2021 Jan; 14(1):47-53. PubMed ID: 32799428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoption of organ-on-chip platforms by the pharmaceutical industry.
    Vulto P; Joore J
    Nat Rev Drug Discov; 2021 Dec; 20(12):961-962. PubMed ID: 34646035
    [No Abstract]   [Full Text] [Related]  

  • 16. Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase.
    Yiu ZZN; Barker JNWN; Barnes MR; Di Meglio P; Emsley R; Reynolds NJ; Smith CH; Warren RB; Griffiths CEM;
    J Invest Dermatol; 2021 Aug; 141(8):1872-1878. PubMed ID: 33771529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to develop therapeutic and translational research collaborations with industry.
    Kleiman RJ; Ehlers MD
    Mol Biol Cell; 2019 Oct; 30(22):2741-2743. PubMed ID: 31609671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Academia and big pharma United.
    Ljunggren HG
    Sci Transl Med; 2014 Jan; 6(217):217ed1. PubMed ID: 24382892
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflict of Interest, Conflicting Interests, and Effective Collaboration Between Academia and Industry on Preclinical and Clinical Cancer Research.
    Rothenburg ML; Johnson DH
    JAMA Oncol; 2017 Dec; 3(12):1621-1622. PubMed ID: 28687825
    [No Abstract]   [Full Text] [Related]  

  • 20. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
    Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS;
    Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.